London-based company LabGenius is utilizing AI-powered technology to revolutionize the process of engineering medical antibodies. Antibodies, which are the body’s natural defense against disease, have been synthesized by pharmaceutical companies since the 1980s to combat diseases like cancer and prevent organ rejection. However, the conventional process of designing antibodies is time-consuming and complex.
LabGenius aims to automate and accelerate the antibody discovery process by making use of DNA sequencing, computation, and robotics. The company’s state-of-the-art lab, located in an old biscuit factory in South London, is equipped with robotic arms, incubators, and DNA sequencing machines. This advanced setup allows for the efficient and precise engineering of antibodies.